Quality Assurance and Quality Control – PST06103 Pharmaceutical Production

NTA Level 6 • Semester 1 • PST06103

Quality Assurance and Quality Control

Pharmaceutical Production • Source Session/Topic 21
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 21: Quality Assurance and Quality Control

Total Session Time: 120 minutes

Pre-requisites

• None

Learning Tasks

By the end of this session students are expected to be able to:

• Explain quality assurance in pharmaceutical manufacturing
• Explain quality control in pharmaceutical manufacturing
• Differentiate between quality assurance and quality control
• Explain quality variations in pharmaceutical manufacturing
• Define documentation in pharmaceutical manufacturing
• List documents required for pharmaceutical manufacturing
• Explain the importance of documentation in pharmaceutical manufacturing

Resources Needed:

• Flip charts, marker pens, and masking tape
• Black/white board and chalk/whiteboard markers
• LCD projector and computer
• Handout 21.1: Raw Material Quality Assurance Monograph

SESSION OVERVIEW

|Step |Time |Activity/ |Content |

| | |Method | |

|1 |05 minutes |Presentation |Introduction, Learning Tasks |

|2 |20 minutes |Presentation |Quality Assurance in Pharmaceutical |

| | | |Production |

|3 |15 minutes |Presentation |Quality Control in Pharmaceutical |

| | | |Production |

|4 |10 minutes |Presentation |Difference between QA and QC |

|5 |30 minutes |Presentation |Quality Variation in Pharmaceutical |

| | | |Production |

|6 |30 minutes |Presentation |Documentation in Pharmaceutical |

| | | |Production |

|7 |05 minutes |Presentation |Key Points |

|8 |05 minutes |Presentation |Evaluation |

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning tasks and clarify

ASK students if they have any questions before continuing

STEP 2: Quality Assurance in Pharmaceutical Production (20 minutes)

• Quality is the totality of features and characteristics of a medicinal

product and its ability to satisfy stated and/ or implied needs

o Quality begins with research and development

o Quality is designed and built in the product

• Quality assurance (QA) is a wide ranging concept covering all matters

that individually or collectively influence the quality of a product

• QA is a totality of the arrangements to ensure that the drug is

continuously of the right quality for the intended use

• Quality assurance is a part of quality management focused on providing

confidence that quality requirements will be fulfilled

• Quality Assurance incorporates GMP (which incorporates QC) and also

includes product design and development with special focus on process

design

o GMP is a part of QA which ensures that products are consistently

produced and controlled to the quality standards appropriate to their

intended use

o Quality relationships in a pharmaceutical industry is;

Quality Management

Quality Assurance

Good Manufacturing Practice (GMP)

Quality Control

• Elements of Quality Assurance circle in Pharmaceutical Manufacturing;

o Research

o Development

o Prototyping

o Documentation

o Raw materials

o Facilities (buildings)

o Equipment

o Personnel and supervision

o Monitoring, feedback, follow-up

• Features of a good QA system;

o It is a process, not an end point

o It must be independent of financial pressures

o Must ensure that quality policies are followed

o Must have final authority in product acceptance, rejection and release

to public

o Must be an integral part in production

o Must be responsible for day-to-day operations and for longer term goal

settings

• Responsibilities of QA include the following;

o QA department is responsible for ensuring that the quality policies

adopted by the company are followed

o Helps to identify and prepare the necessary SOPs relative to the

control of quality

▪ Ensures that SOPs are prepared, approved, used and updated

o It must determine that the products meet all the applicable

specifications and that it was manufactured according to the internal

standards of GMP

o QA is responsible for quality monitoring or audit function

o QA functions to assess operations continually and to advise and guide

them towards full compliance with all applicable internal and external

regulations

o Ensures that proper documentation is followed

▪ Documents are systematic and well kept
▪ Quality manuals are made and staff trained and motivated to

comply

• Primary functions of QA

o Quality control (analytical testing of products)

o Raw materials control (sampling, inspecting and testing of incoming

raw materials)

o Packaging and labelling components (bottles, foils, labels, measures,

cartons)

o Physical inspection of product and operations at critical intermediate

stages

▪ In-process quality control
▪ Batch review
▪ Batch release

o Management of internal audit system

o Handle customers’ feedback and satisfaction

o Management of deviations, incidents and investigations

o Management of GMP training system

o Management of validation system

STEP 3: Quality Control in Pharmaceutical Production (15 minutes)

• Quality control (QC) is a component of GMP concerned with sampling,

specification and testing, documentation and release procedures which

ensure that the necessary and relevant tests are performed and the

product is released for use only after ascertaining its quality

• QC is a part of quality management focused on fulfilling quality

requirements

• Responsibilities of QC

o QC department is responsible for day-to-day control of quality within

the company

o QC plays major role in selection of qualified vendors from whom raw

materials are purchased

▪ Tests representative samples as required
▪ Audit vendor’s operations to determine suitability of the vendor

and degree of compliance with GMPs prior to being approved

o QC is responsible for analytical testing of incoming raw materials

(e.g. assay, titrations etc)

o QC is responsible for analytical testing and inspection of packaging

components, including labelling (e.g. appearance, spectroscopy, loss

on drying etc)

o QC is responsible for conducting in-process testing when required,

perform environmental monitoring, and inspect operations for

compliance

o QC is responsible for conducting required tests on finished products

or dosage forms (e.g. assay, dissolution, content uniformity etc)

o Environmental areas for manufacturing of various dosage forms are

tested and inspected by QC department

o Generally QC is responsible for efficacy, safety, quality and

compliance in pharmaceutical manufacturing

• Objectives of quality control

o To establish quality standards

o To locate quality deviation

o To evaluate methods and processes

o Quick sale of quality products

o Production of standard quality products

o Improvement of quality

• Steps in Quality Control

➢ Devising the control over raw materials

➢ Fixing standards and specifications

➢ Exercising control over production operation

➢ Locating inspection point

➢ Maintaining quality of equipment

➢ Maintaining records

• Advantages of quality control

o Improves quality of production and reduction in product cost

o Uniformity in the production and supply of standard quality to

consumers

o Offering full return of the price paid the consumers and giving

convenience and satisfaction to customers

o Reduction in spoiled production and rejection from consumers and

dealers

o Promotion of exports due to superior and standard quality production

o Reduction in inspection cost

o Making products popular in markets

STEP 4: Difference between QA and QC (10 minutes)

• The differences between Quality Assurance and Quality Control are

summarised in the table bellow

|Quality Assurance (QA) |Quality Control (QC) |

|A set of activities for ensuring|A set of activities for ensuring |

|quality in the process by which |quality in the products. |

|products are developed | |

|It is a managerial tool |It is a corrective tool |

|Aims to prevent defects (a |Aims to identify defects in |

|proactive process) |finished products (a reactive |

| |process) |

|The goal is to improve |The goal is to identify defects |

|development and test processes |after product is developed and |

|so that defects do not arise |before it is released for use |

|when product is being developed | |

|Prevents quality problems |Activities or techniques are used|

|through planned and systematic |to achieve and maintain product |

|activities including |quality, process and services |

|documentation | |

|Establishes quality management |Finds and eliminates sources of |

|system |quality problems to meet |

| |customers’ requirements |

|It is the responsibility of |It is the responsibility of a |

|everyone in the team involved in|specific team that tests the |

|production of the product |product for defects |

|Verification is an example of QA|Validation is an example of QC |

STEP 5: Quality Variation in Pharmaceutical Production (30 minutes)

• Quality variations occur due to mistake or alterations occurring in the

whole process i.e. from reception of raw materials to the final product

in its package

• General sources of product quality variation during manufacturing are;

o Raw materials

▪ Variations among supplier of the same raw material
▪ Variation among batches from the same supplier
▪ Variation within a batch

o Methods

▪ Wrong procedure
▪ Inadequate procedure
▪ Negligence in procedure

o Machines

▪ Variation of equipment for same process
▪ Differences in adjustment of equipment
▪ Aging of machine and improper care

o Personnel

▪ Improper working conditions
▪ Inadequate training
▪ Lack of interest and emotional upheavals
▪ Dishonesty, fatigue and carelessness
• Control of Quality Variation

o Raw materials control

o Raw materials for pharmaceutical production are classified into two

broad groups;

▪ Active or therapeutic raw materials (Active Pharmaceutical

Ingredients)

▪ Inactive or inert raw materials (excipients)

o To control quality variation contributed by raw materials;

▪ Starts before and just after reception of raw materials
▪ Raw materials (active substances, excipients, packaging

materials, printed labelling materials) are received from suppliers

▪ Therefore, there are should be a adequate established system for

the receipt, testing and storage of all raw materials i.e. a good

raw material specifications must be written in precise terminology,

complete and provide specific details of test methods, type of

instruments and manner of sampling

▪ After physical inspection (for active constituents and

excipients: proper container, labels, lot number, expiry date etc;

for packaging materials: colour of label, weight of label, carton,

damage etc) received materials are kept (properly arranged) in a

definite area

▪ Each raw material must be sampled according to standard sampling

procedures and sent to the quality control laboratory for testing

according to written procedures

▪ QA personnel should keep preservation samples of active raw

material to perform all required tests for the raw material (these

preservation samples are kept for at least 7 years or as otherwise

specified)

▪ If raw material passes quality test it is labelled “Passed” and

is accepted and moved to the release storage area

▪ Accepted raw materials should be rotated such that oldest stock

is used first

▪ If a raw material is substandard it is kept in “rejected Area”

and sent back to the supplier

[pic][pic] Refer students to Handout 21.1: Raw Material Quality

Assurance Monograph for further reading

o Control of manufacturing practices

▪ Important issues to control are

Personnel control

▪ Only properly trained persons should work in the industry
▪ There are should be proper selection and training in all

departments i.e. production, packing, labelling etc.

▪ Continuing education should there e.g. seminars, workshops
▪ All personnel should be properly checked and all processes

monitored by highly trained and experienced persons

▪ There are should be a friendly system of reporting errors or

mistakes so that to avoid serious loss or compromise in quality

Equipment and building control

▪ They should be of suitable design, size, construction and

location

▪ Surfaces of equipment should be non-reactive, non-absorptive, and

non-additive

▪ Equipment should be constructed and fitted in such a way that it

is easy to replace, easy to clean, and easy to operate and empty

▪ Buildings should not allow cross contamination e.g. table and

liquid sections should be separated completely

Control of records

▪ All records must maintained (e.g. Master Formula Record, Batch

production record)

▪ All records must be signed by a competent and responsible person
▪ Must be checked by another competent person and countersigned
▪ Records must be in clear language to avoid misinterpretation

Production procedure control

▪ Manufacturing processes are operated as stipulated in established

rules from reception of raw materials up to delivery of final

product

▪ A master formula of a batch (a complete list of ingredients with

their quantities) is delivered to the production department

▪ It contains all the information of that batch i.e. procedures

and equipment to used and precautions to be taken etc

▪ This formula is taken to the store and all materials for the

batch are weighed/measured and delivered to in-process quality

control laboratory (under the quality control department)

▪ Both quality control and production departments are

responsible for the production procedure control

Packaging control

▪ Control of packaging is completed before manufacturing of a

product

▪ When the product reaches the packaging section, it should be

packed in recommended containers and not otherwise

▪ There are should never be any mistakes in case of labelling and

writing of batch numbers etc

▪ Packaging materials should be used according to the nature and

distribution of the product

Distribution control

▪ Samples of each released batch are kept in records (for future

reference)

▪ Samples kept in records are selected during packaging and are in

the same packs as they are marketed

▪ These samples are kept for years in order to examine or test the

materials for any purpose or necessary demand

STEP 6: Documentation in Pharmaceutical Production (30 minutes)

• Documentation means any written statements or proof of any activity in

pharmaceutical manufacturing

• Purpose of documentation

o Defines specifications and procedures for all materials and methods of

manufacture and control

o Ensures all personnel know what to do and when to do it

o Ensures that authorized persons have all information necessary for

release of products

o Ensures documented evidence, traceability, provide records and audit

trail for investigation

o Ensures availability of data for validation, review and statistical

analysis

• Due to the importance given to documentation in pharmaceutical

manufacturing, Good Documentation Practice (GDP) is required

• GDP is a systematic procedure of preparing, checking, verifying, issuing,

storing and retrieval and review of any document

• GDP is an essential part of QA
• Importance of GDP

o Facilitates compliance with GMP and regulatory authorities

o Define manufacturers’ system of information and control

o Minimize risks of misinterpretation and errors caused by oral or

casually written communications

o Provide unambiguous procedures to be followed to provide confirmation

of performance

o Allow calculations to be checked and approved

o Allow tracing of batch history

o Ensure quality of product

• Attributes of good documentation are accurate, clear, complete,

consistent, indelible(isiyofutika), legible(readable), timely, direct,

authentic(real,original) and authorized

• Documents required in pharmaceutical manufacturing include;

o Site Master File (SMF)

▪ This is a document that provides all information of a

pharmaceutical industry (plant)

• Contents of the SMF are;
• General information
• Information related to the organization, manufacturing

activities, name and address, type of products, description of

employees, external technical support and daily management

system

• Personnel and organization chart
• Qualification, experience and responsibilities of key personnel,

training, health requirements and personnel hygiene clothing

• Premises and equipment
• Description of manufacturing area, nature of construction and

finish, brief description of ventilation, special areas, water

system, maintenance of premises, major production and laboratory

equipments, maintenances of equipments, calibrations and

sanitizations

▪ Documents-Preparations, revision and distribution of

documents

▪ Production-Brief description of production operations,

handling of materials, handling of rejected materials and

products, brief description of general policy of process

validation

▪ Quality management system -Quality Assurance (QA), Quality

Control (QC)

▪ Inspection -Self inspection and self inspection programme
▪ Change control-A document for review, approval and

implementation of any change in validated system, equipment,

process and materials

▪ Protocols-Written plan stating how validation is conducted

and defining acceptance criteria

o Specifications

▪ Describes the requirements with which products or materials used

or obtained during manufacture have to conform

▪ They serve as a basis for quality evaluation
▪ Some specifications include;
• Specifications for raw materials (active substances and

excipients)

• Specifications for primary printed and packing materials
• Specifications for intermediate and semi finished product
• Specifications for finished products

o SOPs

▪ For all processes and operations
▪ Guided by the mother SOP

o Test Methods

▪ Describes the detailed test procedures

o Lists

▪ Contain catalogues of any object such as list of equipments

o Certificates of analysis

▪ An authentic document showing the analytical reports and decision

of acceptance or rejection of products

o Labels

▪ For finished products

o Organograms

▪ Showing administration of the company/organization

o Job description

▪ For each personnel

o Master Formula Record (MFR)

▪ It is defined as a document or a set of documents specifying the

starting materials with their quantities and packaging materials,

together with a description of the procedures and precautions

required to produce a specific quantity of a finished product as

well as the processing instructions including the in-process

controls.

▪ It is a master document for any pharmaceutical product
▪ It is also known as Master Manufacturing Record or Master

Production Record

▪ It is prepared by the research and development team of company
▪ It contains all the information about the manufacturing process

for the product

▪ It is used as a reference standard for preparing Batch

Manufacturing Record (BMR) or Batch Production Record (BPR) by

manufacturing units

▪ A Master Formula is required for each product and batch size to

be manufactured (It ensures consistency in production of each

batch)

Contents of MFR

▪ Product details
• Name, logo and address of the manufacturing company
• Name of product (brand name, generic name), dosage form and

strength

• Product code
• Label claim of all ingredients including excipients
• Product description
• Batch size
• Pack size and packing style
• Shelf life
• Storage conditions
• MFR number and date
• Supersede MFR number and date
• Effective batch number
• Authorization by the production and quality assurance head
▪ Flow chart
• Steps of the manufacturing process to be monitored
• Flow chart of the material movement from dispensing to the final

product stores

▪ Equipment
• A all required equipment and machines required in the

manufacturing process with their capacity

▪ Special instructions
• Precautions, special instructions to follow during manufacturing

process and packing (also included in the BMR)

▪ Calculations
• Calculations steps of all active materials to get 100% of the

active material

• The calculations are done using water or LOD to get 100% potency
▪ Manufacturing process
• All steps in all stages of manufacturing process
• All processes like sifting, milling, lubricating, granulation,

compression and coating should be written in detail including

the process time and yield

• Should also include atmospheric conditions such as temperature,

humidity and storage conditions for every step

▪ Packing process
• A list of all packing materials with their quantities (closures,

containers, labels, packaging)

• Line clearance, reconciliation of printed and unprinted packing

materials should be included in the details

▪ Yield
• Theoretical yield, actual yield and acceptance limit of the

batch

o Batch Production Record (BPR)

▪ It is also known as Batch Manufacturing Record (BMR)
▪ It must be prepared, maintained and controlled for each batch of

a product

▪ Batch production record should have the following information
• Name of product
• Generic name, strength, shelf-life, manufacturing date and

expiry date, batch number, code number)

• A complete list of ingredients
• Full description, codes and quantities issued
• Statement of processing location and equipment
• Method or reference to method used for preparing critical

equipment

• Cleaning, assembling, calibration and sterilizing
• Dates and time of all activities
• Line clearance procedure in every step
• Labelling control and specimen for coding in primary, secondary

and tertiary packing materials

• Deviation records
• Statement of control instructions, sampling and testing

procedure, specifications and precautions followed

• Results of tests performed
• A statement of theoretical yield and reconciliation
• Preparation, issues and uses of documents

o All documents should be carefully and logically specified to prevent

wrong uses

o Information must be clear and easy to understand

o Each document should include;

▪ Company name (and logo)
▪ Purpose and title
▪ Identification number and revision number
▪ Date of authorization
▪ Date of review
▪ Signature of prepared by, checked by and authorized by
▪ Distribution list
▪ Page number
▪ Reason for revision
▪ Abbreviations and references

STEP 7: Key Points (5 minutes)

• ..Quality assurance (QA) is a wide ranging concept covering all matters

that individually or collectively influence the quality of a product. It

is a totality of the arrangements to ensure that the drug is continuously

of the right quality for the intended use

• Quality Assurance incorporates GMP (which incorporates QC) and also

includes product design and development with special focus on process

design

• Quality control (QC) is a component of GMP concerned with sampling,

specification and testing, documentation and release procedures which

ensure that the necessary and relevant tests are performed and the

product is released for use only after ascertaining its quality

• QC is a part of quality management focused on fulfilling quality

requirements

• Quality variations occur due to mistake or alterations occurring in the

whole process i.e. from reception of raw materials to the final product

in its package

• Documentation means any written statements or proof of any activity in

pharmaceutical manufacturing

• Due to the importance given to documentation in pharmaceutical

manufacturing, Good Documentation Practice (GDP) is required

• GDP is a systematic procedure of preparing, checking, verifying, issuing,

storing and retrieval and review of any document

STEP 8: Evaluation (5 minutes)

• What is quality assurance?
• How does quality assurance differ from quality control?
• List documents commonly used in pharmaceutical production
• What is Good Documentation Practice?
• What is Master Formula Record?
• What is Site Master File?
• What is Batch Manufacturing Record?

References

Aulton M.E & Kevin M.G, (Eds): (2013) Pharmaceutics: The design and

manufacture of medicines, (4th ed.) Churchill Livingstone

Hugo and Russell (2011), Pharmaceutical Microbiology (8th ed.), Willey-

Blackwel publications

Gennaro, R. A, et al. (Eds) (1995) Remington: The Science and Practice of

Pharmacy, Volume I & II, (19th ed.): Mack Publishing Company, Easton,

Pennsylvania 18042

Liebsch, B et al (1988): Tanzania Pharmaceutical Handbook, Dar es Salaam

University Press.

Lund, W. Editor (1994). The Pharmaceutical Codex, Principles and Practice

of Pharmaceutics (12th ed.): The Pharmaceutical Press, London

Polderman, J., (1990) Introduction to Pharmaceutical Production: Novib, The

Hague

Rawlins E.A, Editor: (1977) Bentley’s Textbook of Pharmaceutics, 8th Ed.

Baillie're Tindall. London Kamm, G. and Kohler, B. Editors: (1995)

Manual for Decentralized Infusion Production, Infusion Unit Project

Tanzania

Schmidt, O. (ed) (2000) Pharmaceutical Quality systems, Interpharm Press,

Colorado.

Shayne C et al (2008), Pharmaceutical Manufacturing Handbook: Production

and processes, John Wiley & Sons

Watson, D. G., (1999) Pharmaceutical Analysis: A Textbook for Pharmacy

Students and Pharmaceutical Chemists: Churchill Livingstone,

Edinburgh.

|[pic] |Handout 21.1: Raw Material Quality Assurance Monograph |

• Raw Material Name

1. Structural formula, Molecular weight

2. Chemical name(s)

3. Item number

4. Date of issue

5. Date of superseded, if any, or new material

6. Signature of writer

7. Signature of approval

• Samples

1. Safety requirement

2. Sample plan and procedure

3. Sample size and sample container to be used

4. Preservation sample required

• Retest programme

1. Retesting schedule

2. Re-analysis to be performed to ensure identity, strength, quality

and purity

• Specifications (wherever applicable)

1. Description

2. Solubility

3. Identity

a. Specific chemical test such as related alkaloids, organic

nitrogen basis, acid moiety or inorganic salts tests (sulphate,

chloride, phosphate, sodium and potassium tests or other spot

organic and inorganic chemical test as needed

b. Infrared absorption

c. Ultraviolet absorption
d. Melting range

e. Congealing point

f. Boling point or range

g. Thin-layer, paper, liquid or gas chromatography

4. Purity and Quality

a. General completeness of solutions (pH, specific rotation, non-

volatile residue, ash, acid insoluble ash, residual on ignition,

loss on drying, water content, heavy metals (arsenic, lead,

mercury), sulphate, chloride, carbonate, acid value, iodine

value, saponification value)

b. Special quality tests (particle size, crystallinity

characteristics and polymorphic forms)

c. Special purity tests (ferric in ferrous salt, peroxide and

aldehydes in ether and related degradation products

5. Assay, calculated either on non-hydrous or hydrous basis

6. Microbial limits (especially for raw materials from natural

sources)

• Test procedures

1. Compendia tests (USP, BP or NF references

2. Non compendia tests (detailed analytical procedure, weights,

dilutions, extractions, normality, reagents, instrumentation used

and procedure if any, calculations)

• Approved Suppliers

1. List of prime suppliers and other approved alternative suppliers,

if any

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top